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Background: Palmitoleic acid was previously shown to improve glucose homeostasis by reducing hepatic glucose
production and by enhancing insulin-stimulated glucose uptake in skeletal muscle. Herein we tested the hypothesis
that palmitoleic acid positively modulates glucose uptake and metabolism in adipocytes.
Methods: For this, both differentiated 3 T3-L1 cells treated with either palmitoleic acid (16:1n7, 200 μM) or palmitic
acid (16:0, 200 μM) for 24 h and primary adipocytes from mice treated with 16:1n7 (300 mg/kg/day) or oleic acid
(18:1n9, 300 mg/kg/day) by gavage for 10 days were evaluated for glucose uptake, oxidation, conversion to lactate
and incorporation into fatty acids and glycerol components of TAG along with the activity and expression of
lipogenic enzymes.
Results: Treatment of adipocytes with palmitoleic, but not oleic (in vivo) or palmitic (in vitro) acids, increased basal
and insulin-stimulated glucose uptake and GLUT4 mRNA levels and protein content. Along with uptake, palmitoleic
acid enhanced glucose oxidation (aerobic glycolysis), conversion to lactate (anaerobic glycolysis) and incorporation
into glycerol-TAG, but reduced de novo fatty acid synthesis from glucose and acetate and the activity of lipogenic
enzymes glucose 6-phosphate dehydrogenase and ATP-citrate lyase. Importantly, palmitoleic acid induction of
adipocyte glucose uptake and metabolism were associated with AMPK activation as evidenced by the increased
protein content of phospho(p)Thr172AMPKα, but no changes in pSer473Akt and pThr308Akt. Importantly,
such increase in GLUT4 content induced by 16:1n7, was prevented by pharmacological inhibition of AMPK with
compound C.
Conclusions: In conclusion, palmitoleic acid increases glucose uptake and the GLUT4 content in association with
AMPK activation.
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White adipose tissue (WAT) plays an important role in
the determination of whole-body energy homeostasis
through the storage and mobilization of energy in pe-
riods of surplus and demand, respectively, along with
the secretion of a large variety of hormones that modu-
late important metabolic processes in body tissues [1,2].* Correspondence: alonsovale@gmail.com
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unless otherwise stated.WAT also contributes to whole-body glucose homeosta-
sis in healthy individuals responding for approximately
15% of total glucose disposal, being this hexose an im-
portant metabolic substrate for energy production and
storage in adipocytes [3,4].
Glucose uptake in adipocytes is carried out independ-
ently of insulin by specific glucose transporters (GLUTs)
namely GLUT1 and GLUT5 located in the plasma mem-
brane that display low efficiency of transport for the hexose
[5]. In the presence of insulin, however, glucose uptake in
adipocytes is drastically enhanced (by 10–20 fold) after
translocation and fusion of intracellular vesicles containingentral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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tion of the canonical insulin receptor substrate (IRS) -
phosphoinositide 3-kinase (PI3K) - Akt pathway [7-9]. In
addition to translocation, insulin through the very same
IRS-PI3K-Akt pathway also modulates GLUT4 protein
content [10,11].
Another intracellular signaling pathway that plays an
important role in the regulation of glucose uptake in adi-
pocytes is the AMP-activated protein kinase (AMPK)
[12,13], a heterotrimeric protein that is activated by the
lower ATP/AMP ratio commonly found in situations of
higher energy demand. Upon its activation, AMPK pro-
motes GLUT4 translocation to the plasma membrane
and glucose uptake independently of insulin [8,13-15].
Along with translocation, AMPK also positively modu-
lates GLUT4 transcription and protein levels [16].
Evidences accumulated over the years have shown that
fatty acids, according to the carbon chain length and
number of double bounds, have the ability to affect rates
of glucose uptake through the modulation of above-
mentioned intracellular signaling pathways [17]. Indeed,
saturated long-chain fatty acids such as palmitic (16:0)
and stearic (18:0) acids were shown to impair glucose
uptake [18,19], whereas monounsaturated n-7 palmito-
leic acid (16:1n7) was found to improve glucose uptake
by affecting insulin responsivity [20]. More specifically
to latter, palmitoleic acid, which is synthesized by the de-
saturation of palmitic acid (16:0) catalyzed by the stearoyl-
CoA desaturase 1 (SCD-1), was shown to improve glucose
homeostasis by enhancing Akt activation and plasma
membrane GLUT1 and GLUT4 protein content in skel-
etal muscle [20-22] and by reducing hepatic esteatosis and
improving insuling signaling in the liver [20,23]. Further-
more, palmitoleic acid was also shown to protect pancre-
atic β-cells from the deleterious effects of palmitic acid
[24,25] and to increase lipolysis and the content of the
major lipases ATGL and HSL in adipose tissue [26].
In the present study, we tested the hypothesis that,
similarly to skeletal muscle, palmitoleic acid is an im-
portant modulator of glucose uptake and metabolism in
adipocytes. For this, adipocytes were evaluated for glu-
cose uptake and metabolism after treatment with palmi-
toleic acid. Putative mechanisms underlying palmitoleic
acid actions in adipocytes were also investigated.
Materials and methods
Animals
All experimental protocols were approved by the Animal
Ethical Care Committee of the Institute of Biomedical
Sciences, University of Sao Paulo, Brazil, (#98/10/
CEUA). Male 8-wk-old C57BL/6 wild type (WT) mice
(from the Animal Facility of the Institute of Biomedical
Sciences, University of Sao Paulo, Sao Paulo, Brazil) were
kept individually in cages at 23°C on a 12:12-h light–darkcycle with food (chow pellet diet; Nuvilab CR1, Nuvital
SA, Colombo, PR, Brazil) and water ad libitum. Mice were
randomly assigned in one of the three groups that re-
ceived 300 mg/kg/day of pure palmitoleic acid (16:1n7),
oleic acid (18:1n9) (Sigma, St. Louis) or water by gavage
[23,26]. Instead of palmitic acid, which requires previous
dissolution in organic solvent prior to administration,
oleic acid was chosen as a control fatty acid for the in vivo
experiments. Oleic acid, similarly to palmitoleic acid, does
not require dissolution prior administration to mice. Ga-
vages were carried daily between 16:00 and 17:00 h. Body
weight and food intake were measured twice throughout
the experiment. After 10 days, 6 h fasted mice were anes-
thetized with isoflurane and killed by cervical disloca-
tion after blood collection through cardiac puncture.
Blood samples were centrifuged at 1,500 rpm for 20 min
at 4°C and serum was stored at −80°C. Adipose fat pads
(epididymal, inguinal and retroperitoneal) were harvested,
weighed and processed as described below.
Adipocyte isolation
Adipocyte isolation was performed as previously de-
scribed [27] with slight modifications. Briefly, epididy-
mal fat pads were digested in Dulbeccos modified Eagle
Medium (DMEM) supplemented with HEPES (20 mM),
sodium pyruvate (2 mM), bovine serum albumin (BSA,
1%), and collagenase type II (1 mg/mL), pH 7.4 at 37°C
in an orbital bath shaker. Isolated adipocytes were fil-
tered and washed three times in the same buffer without
collagenase. A small amount of adipocytes were photo-
graphed under an optical microscope (×100 magnifica-
tion) using a microscope camera (Moticam 1000; Motic,
Richmond, British Columbia, Canada), and mean adipo-
cyte diameter was determined by measuring 50 cells
using Motic-Images Plus 2.0 software.
Cell culture
3 T3-L1 preadipocytes were cultured in DMEM contai-
ning 10% calf serum and penicillin/streptozotocin at 1%
until confluence. After 2–3 days post-confluence, differ-
entiation was induced by a cocktail composed of dexa-
methasone (1 μM), isobutylmethylxanthine (0.5 mM)
and insulin (1.67 μM). After 48 h, medium was replaced
by DMEM with 10% FBS containing 0.41 μM insulin
[28]. Differentiated 3 T3-L1 cells (6 days after cocktail)
were incubated either with vehicle (ethanol 0.05%), or
palmitic acid (16:0, 200 μM) or palmitoleic acid (16:1n7,
200 μM). Because 3 T3-L1 cells are abundant in palmi-
toleic acid, a dose of fatty acids slightly higher than that
commonly found in plasma of rodents and humans was
chosen to challenge these cells in vitro. As evaluated by
membrane integrity and DNA fragmentation (data not
shown), this dose of fatty acid is not cytotoxic or dele-
terious to 3 T3-L1. After 18 h of treatment, cells were
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the presence of fatty acids for 6 h. Treatment with pal-
mitoleic acid for 24 h induced a significant increase in
3 T3-L1 palmitoleic acid content, without affecting cell
levels of palmitic, stearic, oleic, and vaccenic acids [26].
AMPK inhibition was achieved by treatment with 6-
[4-(2-Piperidin-1-ylethoxy)phenyl]-3-pyridin-4-ylpyrazolo
[1,5-a]pyrimidine (Compound C, 20 μM in DMSO) to
the medium containing fatty acids, for 24 h. All reagents
and drugs were purchased from Sigma Chemical Company
(St. Louis, MO, USA).
2-Deoxy-D-glucose (2-DG) uptake
Differentiated 3 T3-L1 cells (~8 × 105cells/well) or
primary epididymal adipocytes (106 cells/mL) were in-
cubated with or without insulin (100 or 10 nmol/L, for
3 T3-L1 and primary adipocytes, respectively) in buffer
composed of (mM): 140 NaCl, 20 Hepes, 5 KCl, 2.5
MgSO4, 1 CaCl2, BSA 1% (pH 7.4), for 20 min at 37°C.
Subsequently, 2-deoxy-D-[3H]-glucose (0.4 mmol/L, 1850
Bq/tube or well) was added and the reaction was allowed
to occur for exactly 4 or 3 min, for 3 T3-L1 and primary
adipocytes, respectively. The reaction was interrupted
by adding 250 μl of ice-cold phloretin (0.3 mmol/L in
Earle's salts, HEPES 10 mm, BSA 1% and DMSO 0.05%).
3 T3-L1 cells were washed with cold PBS, 300 μL of
NaOH 50 mM was added to each well, the plate was ro-
tated for 20 min and 250 μL was collected to measure
the radioactivity (1450 LSC, Couter MicroBeta, Trilux;
PerkinElmer). For epididymal primary adipocytes, 200-μl
aliquots of this final mixture were layered with 200 μl
of silicone oil (density of 0.963 mg/ml) in microfuge
tubes and centrifuged for 10 sec at 11,000 × g. The cell
pellet on the top of the oil layer was collected, trans-
ferred to vials containing scintillation cocktail for radio-
activity measurement.
Glucose oxidation and incorporation into fatty acids and
glycerol of TAG
Differentiated 3 T3-L1 cells (~8 × 105 cells/well) were
incubated in Krebs/Ringer/phosphate buffer (pH 7.4) con-
taining BSA (1%) and [U-14C]-glucose (2 mM, 1850 Bq/
tube or well), saturated with a gas mixture of 95% O2 and
5% CO2, in the presence or absence of insulin (100 nM),
for 2 h at 37°C. Prior to 2 h incubation period, each well
was covered with a piece of Whatman filter paper and the
plate was sealed with parafilm. Following the 2 h incu-
bation, the filter paper was soaked with 0.1 mL of etha-
nolamine to trap the CO2 produced, and 0.2 mL of
8 N H2SO4 was injected into the wells to stop the re-
action. After 45 min of CO2 trapping, the filter paper
was removed and transferred to scintillation vials for
radioactivity counting [29,30]. Then, 2.5 mL of Dole's re-
agent (isopropanol:heptane:H2SO4, 4:1:0.25, vol/vol/vol)were added into the plates for lipid extraction. Right after
the addition of heptane (1.5 mL) and distilled water
(1.5 mL), the tubes were vortexed and the mixture dec-
anted for 5 min. An aliquot of the upper phase was col-
lected into a scintillation vial for determination of the
radioactivity incorporated into TAG. For the estimation
of glucose incorporation into fatty acids and glycerol of
TAG, an aliquot of upper phase was transferred to a
tube containing 1 mL of ethanol (95%) and 250 μL of
KOH (40%) and incubated in a water bath at 60°C for
1 h. After incubation, 2 mL of HCl (3 N) and 2 ml of
heptane were added, tubes were vortexed and the upper
phase was transferred (1 mL) to a scintillation vial for
the determination of glucose incorporation into fatty acids
of TAG. Glucose incorporation into the glycerol fraction
of TAG was calculated by the difference between the in-
corporation of [U-14C]-glucose into TAG and fatty acids.
Incorporation of [1-14C]-acetate into fatty acids
Differentiated 3 T3-L1 cells (~8 × 105cells/well) were in-
cubated in Krebs/Ringer/phosphate buffer (pH 7.4) con-
taining BSA (1%), glucose (2 mM) and [1-14C]-acetate
(1 mM, 1850 Bq/tube or well) for 2 h at 37°C in a water
bath. At the end of incubation, the lipids were extracted
by the Dole's method for measurement of acetate in-
corporation into fatty acids as described above.
Maximal activity of the enzymes involved in the de novo
fatty acid synthesis
The activities of glucose-6-phosphate dehydrogenase
(G6PDH) (EC 1.1.1.49), ATP citrate lyase (ACL) (EC
4.1.3.8) and fatty acid synthase (FAS) (EC 2.3.1.85) were
analyzed. Differentiated 3 T3-L1 (~8 × 105 cells/well)
were homogenized in extraction buffer containing su-
crose (0.25 M), EDTA (1 mM), DTT (1 mM), leupeptin
(20 μg ml−1) and aprotinin (5 μg ml−1) (1:1, pH 7.4) and
centrifuged at 20,000 × g at 4°C for 5 min. The fat cake
free supernatant fraction was used for quantification of
enzyme activities as previously described [31].
Glucose conversion into lactate
Differentiated 3 T3-L1 (~8 × 105 cells/well) were incu-
bated in Krebs/Ringer/phosphate buffer (pH 7.4) con-
taining BSA (1%), glucose (2 mM) for 2 h at 37°C. At
the end of incubation, the medium was collected to meas-
ure the glucose converted into lactate using commercial
kit (Enzymatic Lactate - Labtest Diagnóstica from Lagoa
Santa, MG, Brazil).
RNA extraction and quantitative real-time polymerase
chain reaction (Real-Time qRT-PCR)
Total RNA from 3 T3-L1 cells or epididymal adipocytes
was extracted with Trizol (Invitrogen Life Technologies),
analyzed for quality on agarose gel and absorbance ratios
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to cDNA using the High-Capacity cDNA kit (Applied
Biosystems). Gene expression was evaluated by real-time
qRT-PCR using a Rotor Gene (Qiagen) and SYBR Green
as fluorescent dye with 36B4 as a housekeeping gene. PCR
products were run on agarose gel to confirm the size of
the fragment and specificity of amplification. Some
PCR products were extracted from gel with a kit (Qiagen)
and submitted to sequencing for identity confirmation.
Primers used and annealing tempera0tures are presen-
ted: 36B4 (5′-3′ sense: TAAAGACTGGAGACAAGGTG;
5′-3′antisense: GTGTACTCAGTCTCCACAGA; 63°C;
NM_007475) and GLUT4 (5′-3′ sense: CATTCCCTGGT
TCATTGTGG; 5′-3′ antisense: GAAGACGTAAGGAC
CCATAGC; 60°C; NM_009204).Western blot analysis
For GLUT1 and GLUT 4 total protein content analysis,
3 T3-L1 cells were homogenized and processed in buffer
composed in mM: 10 Tris–HCl, 1 EDTA and 250 su-
crose, 7.4 pH and centrifuged at 1,000 × g for 15 minutes
at 4°C [32,33]. For the analysis of other proteins, 3 T3-
L1 cells were homogenized and processed in buffer com-
posed in mM: 50 HEPES, 40 NaCl, 50 NaF, 2 EDTA, 10
sodium pyrophosphate, 10 sodium glycerophosphate, 2
sodium orthovanadate, 1% Triton-X100, and EDTA-free
protease inhibitors. Identical amounts of protein aliquots
of 3 T3-L1 lysates cells were resolved on Nupage gradi-
ent gels (4-12%, Life Technologies) and transferred to
nitrocellulose membranes. After blockage with 5% milk
for 1 h, membranes were incubated overnight at 4°C with
the following primary antibodies: GLUT 1 (#07-1401),
GLUT4 (#07-1404) (Millipore, Billerica, MA, USA) or Akt
(#9685S), phosphoSer473 Akt (#4060S), phosphoThr308
Akt (#4056), AMPKα (#2532) and phosphoThr172
AMPKα (#2531) (Cell Signaling, Beverly, MA, USA) or
GAPDH (G9545, Sigma) in 5% milk (1:1000). After
washing, membranes were subsequently incubated with
appropriated peroxidase-conjugated secondary antibody
(1:5000) for 1 h and developed using the ECL en-
hanced chemiluminescence substrate (GE Healthcare Life
Sciences, Björkgatan, Uppsala). Densitometric analyses
were performed using the ImageJ software (National Insti-
tutes of Health, Bethesda, MD).Statistical analysis
Data are expressed as mean ± SEM. Student t-Test or
One-Way ANOVA (as indicated in the figure legends)
followed by Tukey post-hoc test were used to compare
the effects of different treatments and conditions. Ana-
lysis was performed using GraphPad Prism 5.0 software
(GraphPad Software, Inc., San Diego, CA, USA). The
level of significance was set at p ≤ 0.05.Results
Confirming our previous study [26], palmitoleic acid
administration to mice for 10 days did not affect body
weight, food intake, adiposity and plasma levels of free
fatty acids, insulin and glucose (data not shown). Des-
pite the absence of changes in these variables, treatment
of mice with 16:1n7, but not 18:1n9 induced a significant
increase in primary epididymal adipocyte basal and
insulin-stimulated glucose uptake in comparison to water
treated control mice (~3-fold and 1.8-fold, respectively,
Figure 1A). Importantly, such increase in glucose uptake
induced by 16:1n7 was associated with a marked upre-
gulation in adipose tissue GLUT4 mRNA levels (~86%,
Figure 1B).
In an attempt to investigate whether palmitoleic acid
enhances glucose uptake by acting directly on adipocytes
and, if so, to unveil mechanisms underlying this action,
we next evaluated the effects of this fatty acid on
3 T3-L1 adipocytes glucose uptake in vitro. In agree-
ment with in vivo findings, 24 h treatment with 16:1n7
significantly increased basal and insulin-stimulated glu-
cose uptake in 3 T3-L1 adipocytes (51% and 36%, re-
spectively, Figure 2A), whereas treatment with 16:0 had
either no effect on basal or significantly reduced insulin-
stimulated glucose uptake (40%) in these cells. Similarly to
in vivo findings, the increase in 3 T3-L1 adipocytes glu-
cose uptake induced by 16:1n7 was associated with a sig-
nificant upregulation in GLUT4 mRNA levels (34%) and
protein content (78%) under basal non-stimulated condi-
tions (Figure 2B and C). No effects of 16:0 were seen on
GLUT4 expression or protein content and, none of these
fatty acids significantly affected GLUT1 protein levels
(Figure 2D).
In face of these changes in glucose uptake, we next
investigated whether 16:1n7 also affects glucose metab-
olism in 3 T3-L1 adipocytes. As depicted in Figure 3A
and B, palmitoleic acid significantly increased insulin-
stimulated glucose conversion into lactate and oxidation
to CO2 in comparison to vehicle treated cells (~29% and
27%, respectively). Treatment with 16:0, on the other
hand, significantly reduced glucose oxidation at both
basal and insulin stimulated conditions, without how-
ever, affecting lactate production from glucose. Despite
having opposite actions on glycolysis, treatment with
both 16:1n7 and 16:0 significantly increased the gene-
ration of glycerol 3-phosphate from glucose (~37% and
21%, respectively), as evidenced by the higher rates of
glucose incorporation in the glycerol fraction of TAG
under basal, but not insulin stimulated conditions in
comparison to vehicle treated cells (Figure 3C).
In contrast to the synthesis of glycerol from TAG,
treatment with both 16:1n7 and 16:0 decreased insulin-
stimulated de novo lipogenesis from all sources and from
glucose as estimated by acetate and glucose incorporation
Figure 1 Basal and insulin-stimulated rates of glucose uptake (Panel A), mRNA levels of glucose transporter 4 (GLUT4, Panel B) in
isolated epididymal adipocytes from mice treated for 10 days by gavage with either water (H2O), oleic acid (18:1n9, 300 mg/kg/day)
or palmitoleic acid (16:1n7, 300 mg/kg/day). Results are means ± SE (n = 5-6/group). *P < 0.05 16:1n7 vs. all groups.
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Treatment with 16:1n7, but not 16:0 also reduced fatty
acid synthesis from glucose at basal non-stimulated condi-
tions. Corroborating with the reduction in lipogenesis, the
maximal activity of ACL, an enzyme that generates acetyl-
CoA in the cytosol for fatty acid synthesis, was signifi-
cantly reduced by treatment with both 16:1n7 and 16:0
(Figure 4C). Indeed, 16:1n7 alone reduced the activity of
G6PDH that catalyzes the generation of NAPDH required
for lipogenesis. No effects of 16:1n7 and 16:0 were seen
on maximal FAS activity (Figure 4D-E).
In an attempt to unveil the mechanisms underlying
the above described 16:1n7 actions in adipocytes, weFigure 2 Basal and insulin-stimulated rates of glucose uptake (Panel
basal protein content of GLUT4 (Panel C) and glucose transporter 1 (G
with either vehicle, palmitic acid (16:0, 200 μM) or palmitoleic acid (1
all groups.next investigated the effects of this fatty acid on the acti-
vation status of major intracellular signaling proteins,
namely Akt and AMPK, previously implicated in the
regulation of glucose uptake and metabolism. As illustra-
ted in the Figure 5A, treatment with either with 16:1n7
or 16:0 did not affect Akt activation in 3 T3-L1 adipo-
cytes as evidenced by the absence of changes in the
content of phospho(p) Ser473 Akt and pThr308 Akt at
non-stimulated conditions. In contrast to Akt, however,
treatment with 16:1n7, but not 16:0, significantly increased
AMPK activity as evidenced by the higher content of
pThr172AMPKα (Figure 5B). Accordingly with a likely
involvement of AMPK activation as a mediator of theA), basal mRNA levels of glucose transporter 4 (GLUT4, Panel B),
LUT1, Panel D) in differentiated 3 T3-L1 cells treated for 24 h
6:1n7, 200 μM). Results are means ± SE (n = 4-8/group). *P < 0.05 vs.
Figure 3 Basal and insulin-stimulated rates of glucose conversion into lactate (Panel A), glucose oxidation (Panel B) and glucose
incorporation into glycerol fraction of triacylglycerol (Panel C), in differentiated 3 T3-L1 cells treated for 24 h with either vehicle,
palmitic acid (16:0, 200 μM) or palmitoleic acid (16:1n7, 200 μM). Results are means ± SE (n = 6-10/group). *P < 0.05 vs. all groups and
#P < 0.05 vs. vehicle.
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cological inhibition of this kinase with compound C
completely blocked the increased in GLUT4 protein
content induced by treatment with 16:1n7 (Figure 5C).
Discussion
Herein we tested the hypothesis that palmitoleic acid
positively modulates glucose uptake and metabolism in
white adipocytes. Through a combination of in vivo and
in vitro experiments, we have found that palmitoleic acid
increases adipocytes glucose uptake and the expression
and content of the major glucose transporter GLUT4.
Along with uptake, palmitoleic acid enhances adipocyte
glucose metabolism through energy-producing insteadof energy-storing pathways as evidenced by the increased
rates of aerobic and anaerobic glycolysis and inhibition of
de novo lipogenesis. Our findings also indicate that at least
part of these palmitoleic acid actions seem to be due to an
increase in AMPK activity induced by this fatty acid in ad-
ipocytes. Altogether our results suggest that palmitoleic
acid is an important positive modulator of adipocytes glu-
cose metabolism through energy producing pathways.
The seminal discovery that palmitoleic acid, a fatty acid
endogenously synthesized by the desaturation of palmitic
acid (16:0) catalyzed by SCD-1, acts as an signaling mol-
ecule that improves glucose homeostasis by enhancing
glucose disposal and insulin sensitivity in skeletal muscle
and by reducing glucose production and lipid deposition
Figure 4 Basal and insulin-stimulated rates of acetate (Panel A) and glucose (Panel B) incorporation in fatty acids of triacylglycerol and
maximal activities of ATP citrate lyase (ACL, Panel C), fatty acid synthase (FAS, Panel D) and glucose-6-phosphate dehydrogenase
(G6PDH, Panel E), in differentiated 3 T3-L1 cells treated for 24 h with either vehicle, palmitic acid (16:0, 200 μM) or palmitoleic acid
(16:1n7, 200 μM). Results are means ± SE (n = 6-8/group). *P < 0.05 vs. vehicle and #P < 0.05 vs. 16:0.
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tions of this fatty acid on adipocytes glucose uptake and
metabolism. Similarly to skeletal muscle, we demonstrate
herein that palmitoleic acid is a positive modulator of glu-
cose uptake and GLUT4 expression and content in white
adipocytes. Importantly, considering our findings that
palmitoleic acid mainly upregulates GLUT4 content and
glucose uptake at basal non-stimulated condition, it is
plausible to envisage that such effect may be also respon-
sible for the enhanced glucose uptake seem upon insulin
stimulation in cells treated with this fatty acid. In agree-
ment with this notion, palmitoleic acid induction of glu-
cose uptake in adipocytes occurred without major changes
on pAkt content, which strongly indicates that other intra-
cellular signaling pathway than the canonical insulin re-
gulated IRS-PI3K-Akt is involved in these actions. These
findings, which are in contrast to previous studies showing
that palmitoleic acid increases pAkt and IRS-1 and 2contents in liver and skeletal muscle [20-22], also indicates
that palmitoleic acid increases glucose uptake in adipo-
cytes through different mechanisms of action. In this
sense, we have found that palmitoleic acid induces a
marked activation of AMPK in adipocytes, a heterotri-
meric kinase activated by an impairment in the ratio
ATP/AMP in situations of increased energy demand
[12,13]. In addition to the activation of GLUT4 trans-
location into the membrane independently of insulin
[13], AMPK is also a positive modulator of GLUT4 expres-
sion and content, such effects that seem to involve the
phosphorylation and activation of peroxisome proliferator-
activated receptor gamma coactivator 1α (PGC1α) and his-
tone deacetylase 5 (HDAC5) [34,35]. Further supporting
our hypothesis that palmitoleic acid increases glucose up-
take and GLUT4 content in adipocytes by activating
AMPK, pharmacological inhibition of this kinase with
Compound C completely blocked the increased in GLUT4
Basal protein content
Figure 5 Basal protein content of phospho(p) Ser473 Akt and pThr308Akt (Panel A) and pThr172 AMP-activated protein kinase alpha
(Panel B) in differentiated 3 T3-L1 cells treated for 24 h with either vehicle, palmitic acid (16:0, 200 μM) or palmitoleic acid (16:1n7,
200 μM). Basal protein content of glucose transporter 4 (GLUT4, Panel C) in differentiated 3 T3-L1 cells treated for 24 h with either vehicle,
palmitoleic acid (16:1n7, 200 μM), Compound C (Comp. C, 20 μM) or palmitoleic acid associated with Compound C (Comp. C + 16:1n7). Results
are means ± SE (n = 3-4/group). *P < 0.05 16:1n7 vs. all groups.
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C has been widely used as a cell-permeable AMPK inhi-
bitor in in vitro and in vivo experiments including those
conducted in adipocytes, a recent study has found that this
drug has a poor specificity targeting other proteins than
AMPK [10,14,36]. Taken this limitation into account,
altogether our findings suggest that palmitoleic acid
similarly to exercise, adiponectin, 5-amino-1-β-D-ribo-
furanosyl-imidazole-4-carboxamide (AICAR), pachymic
acid among others, is an important activator of glucose
uptake in association with AMPK activation [10,14,16,37].
In addition to uptake, palmitoleic acid significantly mo-
dulated glucose flux through its major metabolic pathways
in adipocytes. At basal, non-stimulated conditions, both
palmitoleic and palmitic acids enhanced glucose conver-
sion into glycerol 3-phosphate, the carbon backbone for
fatty acid esterification and TAG synthesis. Although of
unknown underlying mechanism, these findings suggest
that adipocytes adjust rates of glycerol 3-phosphate gener-
ation according to availability of fatty acid, but indepen-
dently of their identity. More specifically to palmitoleicacid, however, we have shown in previous study [26] that
this fatty acid increases glycerol 3-phosphate generation
concomitantly to lipolysis, thus promoting an elevation in
the recycling of lipolysis-derived fatty acid back to TAG.
This process defined as TAG-fatty acid cycling has been
shown to enhance cell energy expenditure and the sensi-
tivity of neuro/hormonal control [38-40]. The absence of
changes in both glucose oxidation and conversion to lac-
tate at basal, non-stimulated conditions indicate, however,
that other substrates than glucose, are being metabolized
to account for the increased demand of energy promoted
by the enhanced TAG-fatty acid cycle.
Upon insulin stimulation, however, palmitoleic acid en-
hanced glucose metabolism to both CO2 and lactate and
significantly reduced de novo fatty synthesis as evidenced
by the impaired incorporation of acetate (total) and glu-
cose into fatty acids and the activities of G6PDH and ACL
enzymes. These findings suggest that in the presence of
insulin, palmitoleic acid favors the activation of energy-
producing instead of energy-storing metabolic pathways.
Similarly to glucose uptake, AMPK may account for at
Bolsoni-Lopes et al. Lipids in Health and Disease 2014, 13:199 Page 9 of 10
http://www.lipidworld.com/content/13/1/199least part of these palmitoleic acid actions, since activa-
tion of this kinase has been shown not only to increase
glucose flux trough glycolysis leading to higher rates of
hexose oxidation [37,41], but also to inhibit de novo
lipogenesis by phosphorylating and inactivating acetyl-
CoA-carboxylase (ACC), thus reducing the conversion
of citosolic acetyl-CoA to malonyl-CoA, a precursor for
fatty acid synthesis [13,42]. Importantly, our findings
that palmitic acid also reduces de novo lipogenesis in
adipocytes not only suggest that this process, similarly
to glycerol 3-phosphate generation, is modulated by cell
fatty acid availability, but also that AMPK may not be
the only mechanism underlying these effects of fatty
acids, since in contrast to palmitoleic acid, palmitic acid
did not affect the activity of this kinase.
Although the mechanisms by which palmitoleic acid
activates AMPK in adipocytes were not elucidated here,
our recent findings that this fatty acid enhances lipolysis
and TAG-fatty cycle [26] suggest a relationship between
these processes. Corroborating this hypothesis, a previ-
ous study has found that lipolysis activation leads to a
significant increase in AMPK activity that seems to be
due to a reduction of 25% in cellular ATP levels associ-
ated to an increase in the activity of acyl-CoA synthase
and fatty acid reesterification into TAG [43]. Further
studies, however, are required to test this hypothesis and
to define the mechanisms by which palmitoleic acid acti-
vates AMPK in adipocytes.
In summary, we have presented evidence that palmito-
leic acid, in addition to its effects on liver and skeletal
muscle, is a key regulator of glucose uptake and me-
tabolism in white adipose tissue. Our data indicate that
palmitoleic acid is an important positive modulator
of glucose uptake and protein and mRNA content of
GLUT4 favoring the cellular glucose utilization towards
energy producing pathways, such effects that seem to
be associated, at least in part, with AMPK activation.
Further studies, however, are required to elucidate the
mechanisms through which palmitoleic acid activates
AMPK and whether adipose tissue contributes to the
improvement in whole body glucose homeostasis in-
duced by this fatty acid.
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